Pharmacy Times

JULY 16, 2025

Tarlatamab established a new standard for relapsed SCLC, with improved survival and easier administration, enhancing treatment accessibility. Zanubrutinib demonstrated sustained efficacy in CLL with del(17p), emphasizing the importance of BTK inhibitors in high-risk hematologic malignancies.

HIV Treatment and Prevention Agents 65

HIV Treatment and Prevention Agents Compounding Pharmacies Immunization Chemotherapy 65

Pharmacy Times

JUNE 10, 2025

Meloxicam injection (Xifyrm; Azurity Pharmaceuticals, Inc) received FDA approval for use in adults for the management of moderate-to-severe pain, either alone or in combination with non-steroidal anti-inflammatory drug (NSAID) analgesics.

FDA 73

FDA HIV Treatment and Prevention Agents Compounding Pharmacies Hospitals 73

Pharmacy Times

JULY 1, 2025

SHOW MORE Pharmacists can help oversee the treatment process to ensure patients with transthyretin amyloid cardiomyopathy (ATTR-CM) are adhering to tafamidis. Ongoing research explores tafamidis' long-term efficacy, potential in other heart failure forms, and combination therapies for enhanced outcomes.

HIV Treatment and Prevention Agents 111

HIV Treatment and Prevention Agents Specialty Pharmacies Compounding Pharmacies Hospitals 111

Pharmacy Times

JUNE 16, 2025

Although the use of colony-stimulating factors (CSFs) is well-established in mitigating severe FN, existing literature suggests there is only an approximate 3% difference in FN rates between various CSF agents. Utilizing colony-stimulating factors (CSFs) decreases the incidence of severe FN.

HIV Treatment and Prevention Agents 73

HIV Treatment and Prevention Agents Chemotherapy Compounding Pharmacies Immunization 73

Pharmacy Times

JUNE 23, 2025

The presentation emphasized early intervention and personalized treatment plans in managing type 2 diabetes, shifting from "treating to failure" to "treating to target." It is not indicated for type 1 diabetes and carries a boxed warning for thyroid C-cell tumors, with unknown risk in humans.

HIV Treatment and Prevention Agents 81

HIV Treatment and Prevention Agents Compounding Pharmacies Immunization FDA 81

Pharmacy Times

JULY 8, 2025

Anti-TNFs remain the only FDA-approved class for pediatric IBD, prompting biosimilar use for cost and accessibility. Further research is needed on the clinical impact, treatment longevity, and cost implications of biosimilar use in pediatric IBD.

HIV Treatment and Prevention Agents 100

HIV Treatment and Prevention Agents Compounding Pharmacies Immunization Hospitals 100

Pharmacy Times

JULY 3, 2025

She emphasizes that treatment options are mostly supportive, making prevention through good hygiene and vaccination essential. Pharmacists play a crucial role in educating high-risk individuals about RSV risks and encouraging vaccination to reduce severe illness.

HIV Treatment and Prevention Agents 81

HIV Treatment and Prevention Agents Compounding Pharmacies Vaccines Hospitals 81